Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheridan

Showing results (201-210 of 7,540) with videos related to

Pageof 754
Sort By:
Nature Biotechnology|January 20, 2022
COVID-19 vaccine makers chase variant-ready vaccinesCormac Sheridan
Nature Biotechnology|June 10, 2015
First oncolytic virus edges towards approval in surprise voteCormac Sheridan
Dental Anaesthesia and Sedation|August 1, 1982
Coping processes in the practice of dentistryP Sheridan
Nature Biotechnology|May 3, 2020
Convalescent serum lines up as first-choice treatment for coronavirusCormac Sheridan
Nature Biotechnology|October 8, 2005
Chiron's manufacturing misfortunes boost competitorsCormac Sheridan
Nature Biotechnology|April 9, 2005
Tysabri raises alarm bells on drug classCormac Sheridan
Nature Biotechnology|September 12, 2006
BioXell: an Italian biotech success story?Cormac Sheridan
Nature Biotechnology|May 7, 2005
EPO neem patent revocation revives biopiracy debateCormac Sheridan
Nature Biotechnology|June 22, 2021
Publisher Correction: Questions swirl around failures of disease-modifying Huntington's drugsCormac Sheridan
Journal of Registry Management|June 1, 2023
COVID-19 Response to Cancer ConferenceCheryl Sheridan
Pageof 754

Showing results (201-210 of 7,540) with videos related to

Sort By:
Pageof 754
Nature Biotechnology|January 20, 2022
COVID-19 vaccine makers chase variant-ready vaccinesCormac Sheridan
Nature Biotechnology|June 10, 2015
First oncolytic virus edges towards approval in surprise voteCormac Sheridan
Dental Anaesthesia and Sedation|August 1, 1982
Coping processes in the practice of dentistryP Sheridan
Nature Biotechnology|May 3, 2020
Convalescent serum lines up as first-choice treatment for coronavirusCormac Sheridan
Nature Biotechnology|October 8, 2005
Chiron's manufacturing misfortunes boost competitorsCormac Sheridan
Nature Biotechnology|April 9, 2005
Tysabri raises alarm bells on drug classCormac Sheridan
Nature Biotechnology|September 12, 2006
BioXell: an Italian biotech success story?Cormac Sheridan
Nature Biotechnology|May 7, 2005
EPO neem patent revocation revives biopiracy debateCormac Sheridan
Nature Biotechnology|June 22, 2021
Publisher Correction: Questions swirl around failures of disease-modifying Huntington's drugsCormac Sheridan
Journal of Registry Management|June 1, 2023
COVID-19 Response to Cancer ConferenceCheryl Sheridan
Pageof 754